4
Changes in Ownership
Atea Pharmaceuticals, Inc. Filed Acc 0000899243-21-003868
Options or other derivatives
- Chief Commercial Officer acquired 117,300 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Vavricka John Chief Commercial Officer | 2021-01-29 | Grant or award · Stock Option (Right to Buy) | +117,300 | 117,300 | D: show line 1 in the form |
Loading xslF345X03/doc4.xml…